Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice
about
Discovering probiotic microorganisms: in vitro, in vivo, genetic and omics approachesSaccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cellsYeast modulation of human dendritic cell cytokine secretion: an in vitro study.The yin and yang of yeast: biodiversity research and systems biology as complementary forces driving innovation in biotechnology.Anti-inflammatory properties of Streptococcus salivarius, a commensal bacterium of the oral cavity and digestive tract.Co-production of bioethanol and probiotic yeast biomass from agricultural feedstock: application of the rural biorefinery conceptCellular and molecular effects of yeast probiotics on cancer.Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro.Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probioticStrain dependent variation of immune responses to A. fumigatus: definition of pathogenic speciesFungal Chitin Induces Trained Immunity in Human Monocytes during Cross-talk of the Host with Saccharomyces cerevisiae.Sequencing-based analysis of the bacterial and fungal composition of kefir grains and milks from multiple sources.Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC).Lessons from probiotic-host interaction studies in murine models of experimental colitis.Systems biology of host-fungus interactions: turning complexity into simplicityNutritional and probiotic supplementation in colitis models.Antimicrobial and probiotic properties of yeasts: from fundamental to novel applicationsProbiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement?Design and evaluation of an oral multiparticulate system for dual delivery of amoxicillin and Lactobacillus acidophilus.Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model.Scientific Opinion on the substantiation of a health claim related to Saccharomyces cerevisiae var. boulardii CNCM I‐3799 and reducing gastro‐intestinal discomfort pursuant to Article 13(5) of Regulation (EC) No 1924/2006Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.Hydrogen peroxide production by lactobacilli promotes epithelial restitution during colitis.
P2860
Q27012682-D0AFD18E-F5DA-4E82-810E-E003404433E8Q28741411-708FB254-1456-4E6A-9CA1-8B184C977C65Q33590266-BCB2CF42-1D92-48DB-ABE8-04C8220A39EDQ33761506-1047EC5E-74B1-4858-ACB1-B3C60988ED18Q34387493-CCAE3F46-24E3-46DC-BFEF-6894324C99C1Q34505216-BE1AAAFB-06C5-48F6-90C1-CD9E4FB2EF15Q36113199-FD20F0D4-945B-4CE6-A2A0-C62A9E70C13BQ36206938-7A00D2AF-29F2-4B33-9F83-965537D9C8ECQ36256310-22A096F2-7246-467C-8C0D-576B524E24D6Q36618715-3DE080BC-93AE-423F-9E8D-698842F8403FQ36778793-332AC1AB-0E1A-4608-8EE6-3190A442DA02Q37027813-5D7A1703-29B4-4577-AE07-2E1277F3B581Q37255990-3FBD73A1-860D-4352-A0DD-BE9B108D92B3Q37542178-FEBFC880-CC1D-4CCB-917B-A013D78E5D6DQ37907198-66E6ECB8-CD4D-4AA9-B834-E1D6880447A9Q38020308-47A3C071-1401-443A-B145-25C779F84854Q38021933-D75EB743-E436-41BD-A641-EB3E6E2F2E9DQ38069827-5258D539-B1C3-4C7D-8BF6-7E6BBAD21981Q38542708-5AC69717-552F-464E-8479-CF82C8157E79Q38829431-9B4DA667-194E-438C-A100-05DC165039B8Q42154194-DA90F21C-41D3-4D0E-A46A-DEF56C834CC8Q47152058-DAB7637C-6A13-4FCD-B6AA-97C18BCC6117Q51365615-B71EC316-3BA1-4677-98D4-A1950FF9959CQ54958013-EC026625-1E9C-4B26-A166-64FC63E857EC
P2860
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@ast
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@en
type
label
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@ast
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@en
prefLabel
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@ast
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@en
P2093
P2860
P356
P1476
Probiotic yeasts: anti-inflamm ...... n experimental colitis in mice
@en
P2093
Georges Pignède
Joëlle Dewulf
Pascal Vandekerckove
P2860
P304
P356
10.3748/WJG.V16.I17.2134
P407
P577
2010-05-01T00:00:00Z